# BurstDR™ micrOdosing stimuLation in De-novo Patients

> **NCT03350256** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 60 (actual)

## Conditions studied

- Pain, Intractable
- Pain, Back

## Interventions

- **DEVICE:** Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient.

## Key facts

- **NCT ID:** NCT03350256
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-30
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-07-02
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350256, "BurstDR™ micrOdosing stimuLation in De-novo Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03350256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*